Folgen
Epaminondas Doxakis
Epaminondas Doxakis
Biomedical Research Foundation, Academy of Athens
Bestätigte E-Mail-Adresse bei bioacademy.gr - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Post-transcriptional regulation of α-synuclein expression by mir-7 and mir-153
E Doxakis
Journal of Biological Chemistry 285 (17), 12726-12734, 2010
5732010
miR-7 and miR-153 protect neurons against MPP+-induced cell death via upregulation of mTOR pathway
A Fragkouli, E Doxakis
Frontiers in cellular neuroscience 8, 182, 2014
1512014
GFRα-4, a new GDNF family receptor
J Thompson, E Doxakis, LGP Piñón, P Strachan, A Buj-Bello, S Wyatt, ...
Molecular and Cellular Neuroscience 11 (3), 117-126, 1998
1261998
Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival
AK Wiggins, G Wei, E Doxakis, C Wong, AA Tang, K Zang, EJ Luo, ...
The Journal of cell biology 167 (2), 257-267, 2004
1142004
microRNAs and the regulation of neuronal plasticity under stress conditions
M Schouten, A Aschrafi, P Bielefeld, E Doxakis, CP Fitzsimons
Neuroscience 241, 188-205, 2013
802013
Unraveling the pathways to neuronal homeostasis and disease: mechanistic insights into the role of RNA-binding proteins and associated factors
S Ravanidis, FG Kattan, E Doxakis
International journal of molecular sciences 19 (8), 2280, 2018
722018
Constitutive translation of human α-synuclein is mediated by the 5′-untranslated region
P Koukouraki, E Doxakis
Open Biology 6 (4), 160022, 2016
622016
Circulating brain‐enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease
S Ravanidis, A Bougea, N Papagiannakis, M Maniati, C Koros, AM Simitsi, ...
Movement disorders 35 (3), 457-467, 2020
612020
Differentially expressed circular RNAs in peripheral blood mononuclear cells of patients with Parkinson's disease
S Ravanidis, A Bougea, D Karampatsi, N Papagiannakis, M Maniati, ...
Movement Disorders 36 (5), 1170-1179, 2021
532021
Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients
S Ravanidis, A Bougea, N Papagiannakis, C Koros, AM Simitsi, I Pachi, ...
Annals of clinical and translational neurology 7 (9), 1594-1607, 2020
522020
RNA binding proteins: a common denominator of neuronal function and dysfunction
E Doxakis
Neuroscience bulletin 30, 610-626, 2014
492014
Differences and developmental changes in the responsiveness of PNS neurons to GDNF and neurturin
A Forgie, E Doxakis, A Buj-Bello, S Wyatt, AM Davies
Molecular and Cellular Neuroscience 13 (6), 430-440, 1999
481999
miRNA regulons associated with synaptic function
M Paschou, MD Paraskevopoulou, IS Vlachos, P Koukouraki, ...
Public Library of Science 7 (10), e46189, 2012
472012
Homeodomain-interacting protein kinase-2 regulates apoptosis in developing sensory and sympathetic neurons
E Doxakis, EJ Huang, AM Davies
Current biology 14 (19), 1761-1765, 2004
452004
Neurofibromin 1 is a miRNA target in neurons
M Paschou, E Doxakis
Public Library of Science 7 (10), e46773, 2012
402012
Principles of miRNA-target regulation in metazoan models
E Doxakis
International journal of molecular sciences 14 (8), 16280-16302, 2013
372013
Selective regulation of trkC expression by NT3 in the developing peripheral nervous system
S Wyatt, G Middleton, E Doxakis, AM Davies
Journal of Neuroscience 19 (15), 6559-6570, 1999
331999
Insights into the multifaceted role of circular RNAs: implications for Parkinson’s disease pathogenesis and diagnosis
E Doxakis
npj Parkinson's Disease 8 (1), 7, 2022
312022
Therapeutic antisense oligonucleotides for movement disorders
E Doxakis
Medicinal research reviews 41 (5), 2656-2688, 2021
302021
Neuronal ELAVL proteins utilize AUF-1 as a co-partner to induce neuron-specific alternative splicing of APP
A Fragkouli, P Koukouraki, IS Vlachos, MD Paraskevopoulou, ...
Scientific Reports 7 (1), 44507, 2017
302017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20